Andreas Wagner sells ALHC shares under Rule 144 (ALHC)

Rhea-AI Filing Summary

Alignment Healthcare reported Rule 144 sale notices covering transactions by Andreas Wagner and planned dispositions of vested restricted stock units. The filing lists two recent sales: 21,118 shares sold on 03/04/2026 for $393,250.95 and 22,238 shares sold on 02/10/2026 for $455,211.86.

The filing also lists vested restricted stock units acquired on 03/13/2024 (15,000 shares) and 03/13/2025 (8,602 shares) that are described as securities to be sold.

Insights

Securities Compliance Specialist

Rule 144 notices document reported sales and list vested RSUs that may be sold.

These entries show two completed dispositions by Andreas Wagner totaling $848,462.81 in proceeds across 02/10/2026 and 03/04/2026, using a Rule 10b5-1 plan for at least one trade as stated.

Separately, the form lists 15,000 and 8,602 shares acquired from RSU vesting on 03/13/2024 and 03/13/2025; these entries identify shares that are eligible for sale under Rule 144 but do not specify timing or distribution method.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	E-Trade Finance PO Box 101600 Arlington VA 22210-4600	13271	225466.25	204296493	03/18/2026	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/13/2024	The Common Stock was acquired through the vesting of restricted stock units granted on 03/13/2024 under the Issuer's 2021 Equity Incentive Plan	Alignment Healthcare, Inc. (Issuer)			15000	03/13/2024	n/a
Common Stock	03/13/2025	The Common Stock was acquired through the vesting of restricted stock units granted on 03/13/2025 under the Issuer's 2021 Equity Incentive Plan	Alignment Healthcare, Inc. (Issuer)			8602	03/13/2025	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Andreas Wagner Rule 10b5-1 Plan 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	03/04/2026	21118	393250.95
Andreas Wagner 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	02/10/2026	22238	455211.86

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider sales did Alignment Healthcare (ALHC) disclose?

The filing discloses Andreas Wagner sold 21,118 shares on 03/04/2026 for $393,250.95 and 22,238 shares on 02/10/2026 for $455,211.86. These are reported as Rule 144 notices.

Which vested equity holdings are listed for potential sale in the ALHC filing?

The filing lists vested restricted stock units acquired on 03/13/2024 totaling 15,000 shares and on 03/13/2025 totaling 8,602 shares as securities to be sold under Rule 144.

Were any sales reported as part of a 10b5-1 plan in the ALHC Form 144?

Yes; one sale is identified as effected under an Andreas Wagner Rule 10b5-1 Plan. The filing explicitly associates at least some transactions with that trading plan.

How much aggregate proceeds are shown from the disclosed sales?

The two disclosed transactions show aggregate proceeds of $848,462.81, combining $455,211.86 and $393,250.95 as listed for the two sales.

Does the filing specify timing or method for selling the vested RSU shares?

The filing lists the RSU vesting dates and share counts (15,000 and 8,602) but does not specify sale timing or distribution methods for those vested shares in the provided excerpt.